⋮
0
0
Vedolizumab (Entyvio®) Achieves Superior Rates of Clinical Remission vs. Adalimumab (Humira®) in First Ever Head-to-Head Biologic Clinical Study in Ulcerative Colitis
Showing live article 1176 of 3352 in channel 19681208
Article Details:
Author:
Language: Japanese
Channel Number: 19681208
Article Number: 1176
Date: March 8, 2019, 3:50 pm
URL: http://www.qlifepro.com/press/20190309-17-38732/takeda-pharmaceutical-169/
GUID: http://www.qlifepro.com/press/?p=38732
←
$
X
X
NSFW?
Claim
0
X
Mark channel Not-Safe-For-Work?
cancel
confirm
NSFW Votes:
(
0
votes)
X
Are you the publisher?
Claim
or
contact us about
this channel.
X
0
X
RSSing.com
Search
Sharing:
Title:
URL:
Copy Share URL